[p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide]

Jin-Jun Zhu1, Wei-Ming Liao, Fo-Bao Li

  • 1Institute of Orthopedic Oncology, Department of Orthopedic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, PR China.

Abstract

Insights

The ING1 tumor suppressor enhances osteosarcoma cell sensitivity to etoposide chemotherapy. Overexpressing p33(ING1b) boosts apoptosis and increases p53, p21(WAF1), and Bax protein levels, suggesting a p53-dependent mechanism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • ING1 is a novel tumor suppressor gene with functions similar to p53.
  • ING1 plays a role in cell cycle arrest, DNA repair, apoptosis, and chemosensitivity.

Purpose of the Study:

  • To investigate the impact of p33(ING1b) on osteosarcoma chemosensitivity.
  • To elucidate the underlying molecular mechanisms of p33(ING1b)-mediated chemosensitivity.

Main Methods:

  • Overexpression of p33(ING1b) in U2OS osteosarcoma cells via transient transfection.
  • Treatment with etoposide and assessment of cell growth inhibition and apoptosis.
  • Analysis of p53, p21(WAF1), MDM2, and Bax protein expression using Western blot.

Main Results:

  • p33(ING1b) overexpression significantly increased cell growth inhibition and etoposide-induced apoptosis.
  • Ectopic p33(ING1b) enhanced the protein expression of p53, p21(WAF1), and Bax.
  • MDM2 protein levels showed no significant alteration.

Conclusions:

  • p33(ING1b) up-regulates p53 protein expression.
  • p33(ING1b) cooperates with p53 to enhance p21(WAF1) and Bax expression.
  • These effects contribute to increased etoposide-induced apoptosis through p53-dependent pathways.